Expression of 5-HT1b receptors in human nasal mucosa

Acta Oto-Laryngologica

Volumn 121, Issue 3, 2001, Pages 403-406

  Uddman, Rolf ^a   Longmore, Jenny ^b   Cardell, Lars Olaf ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Human nasal mucosa; Immunocytochemistry; Serotonin receptors

Indexed keywords

SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; HTR1B PROTEIN, HUMAN; SEROTONIN RECEPTOR;

ARTICLE; BLOOD VESSEL; BLOOD VESSEL TONE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN RELEASE; SMOOTH MUSCLE FIBER; ADULT; FEMALE; MALE; MICROCIRCULATION; NOSE OBSTRUCTION; PATHOLOGY; TRIGEMINUS GANGLION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADULT; FEMALE; HUMANS; MALE; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; NASAL MUCOSA; NASAL OBSTRUCTION; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; TRIGEMINAL GANGLION;

EID: 0035317625     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/000164801300102932     Document Type: Article

References (29)

1. Habib YA, Belal A, el-Garem A, el-Lozy M, el-Banna HM, Toppozada H. Serotonin in nasal allergy. Acta Allergol 1971; 26: 39-48.
2. O'Connor RD, Ring J, Jalowayski AA, Hamburger RN. The in vitro effects of levamisole on lymphocyte proliferation, polymorphonuclear leucocyte chemotaxis, basophil histamine release and platelet serotonin release in patients with atopic dermatitis. Clin Allergy 1980; 10: 705-13.
3. Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
4. Saxena PR, Villalon CM. Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 1990; 15 (Suppl 7): 17-34.
5. Tönnesen P, Mygind N. Nasal challenge with serotonin and histamine in normal persons. Allergy 1985; 40: 350-3.
6. Raffestin B, Cerrina J, Boullet C, Labat C, Benveniste J, Brink C. Response and sensitivity of isolated human pulmonary muscle preparations to pharmacological agents. J Pharmacol Exp Ther 1985; 233: 186-94.
7. Stone RA, Worsdell YM, Fuller RW, Barnes PJ. Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 1993; 74: 396-401.
8. 1D receptor family. EMBO J 1992; 11: 4779-86.
9. 1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 1999; 456: 63-7.
10. 1D receptor genes. Trends Pharmacol Sci 1992; 13: 152-9.
11. 1D receptors. Neuropharmacology 1997;36: 513-24.
12. 1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: Clues for function. Neuroscience 1998; 82:469-84.
13. Nilsson T, Longmore J, Shaw D, et al. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol 1999; 372: 49-56.
14. Maassen van den Brink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998; 98: 25-30.
15. Humphrey PPA, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991; 12: 444-6.
16. Weinshank RL, Zgombick JM, Macchi M, Branchek TA, Hartig PR. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci USA 1992; 89: 3630-4.
17. 1 receptors in migraine pathophysiology and treatment. Eur J Neurol 1995; 2: 5-21.
18. Ferrari MD. Migraine. Lancet 1998; 351: 1043-51.
19. Brown EG, Endersby CA, Smith RN, Talbot JC. The safety and tolerability of sumatriptan: An overview. Eur Neurol 1991; 31: 339-44.
20. Hamel E, Fan E, Linville D, Ting V, Villemure JG, Chia LS. Expression of mRNA for the serotonin 5-hydroxytryptamine 1D receptor subtype in human and bovine cerebral arteries. Mol Pharmacol 1993; 44: 242-6.
21. Jansen I, Olesen J, Edvinsson L. 5-Hydroxytryptamine receptor characterisation of human cerebral, middle meningeal and temporal arteries: Regional differences. Acta Physiol Scand 1993; 147: 141-50.
22. 1B receptors in human cerebral arteries: Pharmacological characterization and localisation with immunocytochemistry. Br J Pharmacol 1999; 128: 1133-40.
23. 1Dα serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development. Proc Natl Acad Sci USA 1994; 91: 3666-9.
24. Bouchelet I, Cohen Z, Bruce C, Seguela P, Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 1996; 50: 219-23.
25. 1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia 1997; 17: 833-42.
26. Tönnesen P. Bronchial challenge with serotonin in asthmatics. Allergy 1985; 40: 136-40.
27. Tönnesen P. Effect of topically applied atropine, methysergide and chlorpheniramine on nasal challenge with serotonin. Allergy 1985; 40: 616-9.
28. Tönnesen P, Hindberg I. Serotonin in nasal secretion. Allergy 1988; 43: 303-9.
29. Tönnesen P, Hindberg I, Schaffalitzky de Muckadell OB, Mygind N. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Allergy 1988; 43: 310-7.